159 related articles for article (PubMed ID: 12973848)
1. High incidence of thromboembolism in patients with central nervous system lymphoma.
Goldschmidt N; Linetsky E; Shalom E; Varon D; Siegal T
Cancer; 2003 Sep; 98(6):1239-42. PubMed ID: 12973848
[TBL] [Abstract][Full Text] [Related]
2. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
Peterman CM; Kolansky DM; Spinler SA
Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis.
Gerber DE; Segal JB; Salhotra A; Olivi A; Grossman SA; Streiff MB
Cancer; 2007 Jan; 109(2):300-5. PubMed ID: 17154163
[TBL] [Abstract][Full Text] [Related]
6. Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system.
Dorfman M; Chan SB; Maslowski C
J Clin Pharm Ther; 2006 Oct; 31(5):455-9. PubMed ID: 16958823
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism: application and effectiveness of the American College of Chest Physicians 2001 guidelines for prophylaxis.
Steier KJ; Singh G; Ullah A; Maneja J; Ha RS; Khan F
J Am Osteopath Assoc; 2006 Jul; 106(7):388-95. PubMed ID: 16912336
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?
Koya MP; Manoharan M; Kim SS; Soloway MS
BJU Int; 2005 Nov; 96(7):1019-21. PubMed ID: 16225520
[TBL] [Abstract][Full Text] [Related]
9. [Postoperative recurrence of venous thromboembolism in patients with episodes of preoperative thromboembolism].
Kuroiwa M; Arai M; Nakahara E; Hoka S
Masui; 2003 Jul; 52(7):744-9. PubMed ID: 12910975
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism and survival in patients with high-grade glioma.
Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism in pediatric patients with brain tumors.
Tabori U; Beni-Adani L; Dvir R; Burstein Y; Feldman Z; Pessach I; Rechavi G; Constantini S; Toren A
Pediatr Blood Cancer; 2004 Nov; 43(6):633-6. PubMed ID: 15390288
[TBL] [Abstract][Full Text] [Related]
13. Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study.
Scarpa RM; Carrieri G; Gussoni G; Tubaro A; Conti G; Pagliarulo V; Mirone V; De Lisa A; Fiaccavento G; Cormio L; Bonizzoni E; Agnelli G;
Eur Urol; 2007 Jan; 51(1):130-5; discussion 136. PubMed ID: 16942832
[TBL] [Abstract][Full Text] [Related]
14. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study of venous thromboembolic and intracerebral hemorrhagic events in glioblastoma patients.
Pan E; Tsai JS; Mitchell SB
Anticancer Res; 2009 Oct; 29(10):4309-13. PubMed ID: 19846992
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
Otten HM; Mathijssen J; ten Cate H; Soesan M; Inghels M; Richel DJ; Prins MH
Arch Intern Med; 2004 Jan; 164(2):190-4. PubMed ID: 14744843
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological thromboembolic prophylaxis for medical patients in a tertiary care, teaching community hospital: room for improvement.
Jubelirer SJ; Reyes Bj; Broce M; Elhabyan AK; Mimnagh K; Rosencrance JG; Warwick T; Emmett MK
W V Med J; 2008; 104(1):10-4. PubMed ID: 18335779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
